Audio Clinical Professionals

Pharmacology and Metabolism of Anti-Epileptic Drugs

This session reviews Pharmacology and Metabolism of Anti-Epileptic Drugs and its most clinically relevant points for exam preparation and bedside decision-making.

This resource is private and requires a subscriber login to stream. SIGN IN to continue.

Duration

00:02:47

File size

1.62 MB

Practitioner-Guided Note

For Pharmacology and Metabolism of Anti-Epileptic Drugs, prioritize GABA-ergic enhancement (valproate, barbiturates, benzodiazepines, gabapentin), Sodium channel blockade (phenytoin, carbamazepine, lamotrigine), and T-type calcium channel targeting for absence seizures (ethosuximide) when choosing therapy, counseling about risk, planning monitoring, and deciding when closer follow-up or escalation is needed.

Key Takeaways

GABA-ergic enhancement (valproate, barbiturates, benzodiazepines, gabapentin); Sodium channel blockade (phenytoin, carbamazepine, lamotrigine); T-type calcium channel targeting for absence seizures (ethosuximide); Benzodiazepines increase chloride channel opening frequency, barbiturates prolong channel duration; Cenobamate modulates both sodium channels and GABA